UKMenCar4: a cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence

UKMenCar4: a cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence

Carriage of Neisseria meningitidis , the meningococcus, is a prerequisite for invasive meningococcal disease (IMD), a potentially devastating infection that disproportionately afflicts infants and children. Humans are the sole known reservoir for the meningococcus, and it is carried asymptomatically...

Bibliografske podrobnosti
Main Authors:	Bratcher, H, Rodrigues, C, Finn, A, Wootton, M, Cameron, C, Smith, A, Heath, P, Ladhani, S, Snape, M, Pollard, A, Cunningham, R, Borrow, R, Trotter, C, Gray, S, Maiden, M, Maclennan, J
Format:	Journal article
Izdano:	F1000 Research 2019

Podobne knjige/članki

Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1–4 cross-sectional survey results
od: Maclennan, J, et al.
Izdano: (2021)

Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey results
od: MacLennan, JM, et al.
Izdano: (2021)

The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease.
od: Kugelberg, E, et al.
Izdano: (2010)

The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease.
od: Elisabeth Kugelberg, et al.
Izdano: (2010-02-01)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
od: Read, R, et al.
Izdano: (2014)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial
od: Read, R, et al.
Izdano: (2014)

Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy.
od: Jeppesen, C, et al.
Izdano: (2015)

Risk factors for acquisition of meningococcal carriage in the African meningitis belt
od: Cooper, L, et al.
Izdano: (2019)

Evolutionary and genomic insights into meningococcal biology
od: Bratcher, H, et al.
Izdano: (2012)

B Part Of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine program on carriage of Neisseria meningitidis
od: Marshall, H, et al.
Izdano: (2019)

Beyond direct protection: Meningococcal vaccine effects on carriage
od: A. Finn
Izdano: (2014-04-01)

Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme
od: Carr, JP, et al.
Izdano: (2022)

Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.
od: Maiden, M, et al.
Izdano: (2008)

Meningococcal polysaccharide-protein conjugate vaccines.
od: Snape, MD, et al.
Izdano: (2005)

Enter B and W: two new meningococcal vaccine programmes launched.
od: Ladhani, S, et al.
Izdano: (2016)

Enter B and W: two new meningococcal vaccine programmes launched
od: Ladhani, S, et al.
Izdano: (2015)

MODELLING THE IMPACT OF COVID-19 AND ROUTINE MENACWY VACCINATION ON MENINGOCOCCAL CARRIAGE AND DISEASE IN THE UK.
od: L. Hadley, et al.
Izdano: (2023-05-01)

Alternative molecular methods for improved detection of meningococcal carriage and measurement of bacterial density
od: Manigart, O, et al.
Izdano: (2016)

Meningococcal vaccines.
od: Collins, C, et al.
Izdano: (2002)

Meningococcal meningitis presenting postinfant group B meningococcal immunisation
od: So, N, et al.
Izdano: (2018)

Characterization of meningococcal carriage isolates from Greece by whole genome sequencing: Implications for 4CMenB vaccine implementation
od: Kesanopoulos, K, et al.
Izdano: (2018)

Control of invasive meningococcal disease: is it achievable?
od: Marshall, H, et al.
Izdano: (2016)

Meningococcal disease
od: Pollard, A
Izdano: (2018)

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: A community study
od: Daugla, D, et al.
Izdano: (2013)

Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
od: Snape, MD, et al.
Izdano: (2009)

Molecular Characteristics and Epidemiology of Meningococcal Carriage, Burkina Faso, 2003
od: Judith E. Mueller, et al.
Izdano: (2007-06-01)

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016
od: Helen Campbell, et al.
Izdano: (2017-07-01)

Meningococcal vaccines.
od: Rüggeberg, J, et al.
Izdano: (2004)

Meningococcal vaccines.
od: Bethell, D, et al.
Izdano: (2002)

Meningitis and meningococcal septicaemia.
od: Pollard, A, et al.
Izdano: (1998)

Epidemic meningococcal disease in sub-Saharan Africa--towards a sustainable solution?
od: Pollard, A, et al.
Izdano: (2003)

The impact of meningococcal conjugate vaccine (MenACWY-TT) on meningococcal carriage in Hajj Pilgrims returning to Turkey
od: Hasan Tezer, et al.
Izdano: (2020-06-01)

Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil.
od: Amélia Maria Pithon Borges Nunes, et al.
Izdano: (2016-01-01)

Meningococcal Carriage among Household Contacts of Patients with Invasive Meningococcal Disease in Kathmandu, Nepal: A Longitudinal Study
od: Supriya Sharma, et al.
Izdano: (2021-06-01)

Localized Hypermutation is the Major Driver of Meningococcal Genetic Variability during Persistent Asymptomatic Carriage
od: Luke R. Green, et al.
Izdano: (2020-04-01)

Vaccines for prevention of meningococcal disease.
od: Pollard, A, et al.
Izdano: (2000)

Meningococcal Carriage: Epidemiology, Causative Agent, Inducing of Immune Protection
od: N. N. Kostyukova, et al.
Izdano: (2017-10-01)

Emergency management of meningococcal disease.
od: Pollard, A, et al.
Izdano: (1999)

Meningococcal polysaccharide-protein conjugate vaccines (vol 5, pg 21, 2005)
od: Snape, MD, et al.
Izdano: (2005)

Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy
od: Pace, D, et al.
Izdano: (2016)